Nuveen »

Lineage Cell Therapeutics In shares owned by Nuveen

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $322k 245k 1.31
2025-03-31 $233k 515k 0.45

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Capital Management
Defender Capital
Geode Capital Management
Raffles Associates
Fifth Third Bancorp
Millennium Management
Morgan Stanley
Vanguard Fiduciary Trust
Northern Trust
Renaissance Technologies
Marshall Wace
Vanguard Portfolio Management
State Street Corporation

View all funds holding Lineage Cell Therapeutics In